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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S204have been limited by study populations which are not generalizable to
the general population, are limited to small joint OA or did not adjust for
important prognostic factors such as cigarette smoking or body size.
The aim of our study was to examine whether measures of knee and hip
OA at baseline examination are associated with death before ﬁrst fol-
low-up in a large community-based cohort.
Methods: Data from the Johnston County Osteoarthritis Project were
analyzed to investigate the association between large joint OA and
all-cause death. Analyses were carried out using baseline OA data
from 3,465 individuals aged 45 or older who entered the cohort
during the original study enrollment (1990–1997) and new enrolls
recruited during the cohort enrichment (2003–2004). Vital status
was assessed during ﬁrst follow up period (1999–2004 for original
participants; 2007–2010 for new enrolls). Radiographic OA (rOA) was
deﬁned as a Kellgren-Lawrence (KL) grade of 2 in a knee or hip at
baseline clinical assessment. Severe rOA was deﬁned as a KL grade of
3. Symptomatic OA (sxOA) was a subset of those with rOA and
symptoms in the same joint. Multilevel logistic regression models
controlling for the primary sampling unit (PSU) were used to model
the association between rOA measures at baseline and whether a
death occurred before the ﬁrst follow-up evaluation. To explore
whether the association between rOA and mortality differed by sex,
statistical tests for interaction and stratiﬁed logistic models were
used. All models were adjusted for age, sex, obesity, smoking status,
stroke, diabetes and heart disease.
Results: The baseline sample was 63.0% female, 32.4% African-Ameri-
can, with mean age 61.8 years and mean BMI 29.3 kg/m2; 30.7% had
knee rOA, and 25.1% had hip rOA. By the ﬁrst 5-year follow-up, there
were 495 deaths. No associationwas observed between the knee rOA or
hip rOAwith a KL grade of 2 and all-cause death. However, those with
more severe knee rOA (KL grade 3) had a nearly 50% increase in odds
of death and those with severe hip OA were 25% more likely to die
(latter not statistically signiﬁcant, Table 1). Similar results were
observed in analyses evaluating symptomatic severe knee rOA, (OR ¼
1.49, 5% CI ¼ 1.05–2.11). We observed no statistically signiﬁcant effect
modiﬁcation by sex.
Conclusion: Severe knee rOA and sxOAwere positively associated with
death, independently of demographics, smoking, body size, and rele-
vant comorbidities, in a population-based study, suggesting a role for
systemic effects for large joint rOA and symptomatic OA that warrants
further investigation.Table 1
Adjusted odds ratios (aORs) for all-cause death comparing different types of rOA in
the Johnston County Osteoarthritis Project
Deaths/Alive aORy (95% CI) aORx (95% CI)
Has Knee rOA
No 262/1868 Ref. Ref.
Yes 196/815 1.10 (0.88–1.38) 1.14 (0.90–1.45)
Has Severe Knee rOA
No 362/2393 Ref. Ref.
Yes 94/279 1.41 (1.06–1.89) 1.49 (1.10–2.02)
Has Knee SxOA
No 326/2162 Ref. Ref.
Yes 114/475 1.11 (0.86–1.44) 1.11 (0.85–1.46)
Has Severe Knee SxOA
No 372/2433 Ref. Ref.
Yes 68/204 1.45 (1.04–2.01) 1.49 (1.05–2.11)
Has Hip rOA
No 294/1950 Ref. Ref.
Yes 164/733 1.10 (0.87–1.38) 1.10 (0.87–1.39)
Has Severe Hip rOA
No 435/2607 Ref. Ref.
Yes 22/66 1.24 (0.72–2.12) 1.25 (0.72–2.17)
Has Hip SxOA
No 391/2378 Ref. Ref.
Yes 62/261 1.15 (0.83–1.59) 1.06 (0.76–1.47)
Has Severe Hip SxOA
No 443/2608 Ref. Ref.
Yes 10/13 1.25 (0.56–2.82) 1.11 (0.48–2.56)
yAdjusted for age and sex; Controlling for PSU.
xAdjusted for age, sex, BMI, smoking, stroke, diabetes, heart disease; Controlling for
PSU.356
BODY FAT IS AN INDEPENDENT RISK FACTOR FOR OSTEOARTHRITIS
IN THE STATISTICS CANADA CANADIAN HEALTH MEASURES SURVEY
POPULATION
K.H. Collins y, R. Chin y, C. Sanmartin z, R.A. Reimer y, W. Herzog y,
D.A. Marshall y. yUniv. of Calgary, Calgary, AB, Canada; z Statistics Canada,
Ottawa, ON, Canada
Osteoarthritis (OA) is a multifactorial degenerative disease that is the
most common cause of disability in Canada, affecting more than 4.6
million Canadians. By 2040, it is estimated that 1 in 4 Canadianswill have
OA. Recently, the Canadian Joint Replacement Registry, in a study (n ¼
9,706) determined that 54% of individuals who receive knee replace-
ments areobese. Obesity is one of only fewknownmodiﬁable risk factors
forOAand is generallycalculated using bodymass index (BMI is themass
(kg) divided by the height (m) squared; BMI¼ height (kg)/ height2 (m2)).
However, BMI does not account for composition of mass. Increases in
body fat are associated with increased cytokine and adipokine pro-
ductionwhich in turn causes low-grade systemic inﬂammation. By only
evaluating the effect of BMI on OA, valuablemechanistic information for
the role of adiposity in OA may be missed. However, not all OA patients
have increased body fat or metabolic risk factors. Recently, a subtype of
OA,metabolic OA, has been suggested tohave a unique disease trajectory
independent from the mechanical contribution to joint load.
Purpose: The purpose of this study is to determine if body fat, as
measured by anthropometric skinfold, is independently associated with
patient-reported OA status in a cross-sectional study design from sur-
vey data.
Methods: The Canadian Health Measures Survey (CHMS) was the ﬁrst
comprehensive and representative direct health measures study since
the 1978–1979 Canada Health Survey. Approximately 96% of Canadians
were represented and CHMSdatawas collected in two cycles, from2007–
2009 and 2009–2011, at 15 sites. It included household and mobile
examination unit measurements from 11,387 individuals age 3–79 years
old. Data from the two CHMS cycles were combined according to
methods described by Statistics Canada. Inclusion criteria were applied
(age 40–69, valid BMI measurement, valid body fat percentage, not
pregnant, not hemophiliac, no chemotherapy for the last 4 weeks, no
major surgery in the last 3 months, and no neuromuscular disorder,
amputation, vertebral disorder). Individuals with a BMI greater than
30kg/m2 were excluded as they did not have skinfold measurements
taken. Sample estimates were weighted and bootstrapped standard
errors were obtained to account for the survey design. An adjusted
logistic regression model was built using the following factors: age, body
fat percentage (calculated by a 4-point sex-speciﬁc Durnin &Wormersley
equation), waist circumference, absolute weight change (highest adult
weight – lowest adult weight ever), blood creatinine, blood vitamin D,
and hypertension/cardiovascular disease (CVD). These factors were used
to estimate the odds ratio of each factor for the outcome, patient-
reported OA, deﬁned by responding “osteoarthritis” when asked “What
kind of arthritis do you have?”. Type II diabetes was not included in the
model due to low frequency restrictions as outlined by Statistics Canada.
Results: 2656 individuals age 40–69 were included in the analysis.
Approximately 51.5%were female, mean BMIwas 25.3 0.1 kg/m2,mean
body fatwas 27.5 0.2%, 4.5 0.5%hadhypertension/CVD, and3.0 0.5%
had type II Diabetes. The average waist circumference was 87.9  0.4cm
and average absolute weight change was 17.8  0.4 kg. Of these individ-
uals, 236 (8.9%) reported OA. The average body fat percentage of OA
individuals was higher than non-OA (30.2  0.9% compared with 27.3 
0.2%, p ¼ 0.0071), and no differences were found in BMI between the OA
and non-OA groups (24.9 0.3 kg/m2 comparedwith 25.3 0.1 kg/m2, p
¼ 0.25). OA patients had lower blood creatinine (72.3  1 umol/L com-
paredwith 76.0 0.5 umol/L, p¼ 0.003) and increased plasmaVitamin D
(78.1 2.4 nmol/L compared with 67.0 1.1 nmol/L, p¼ 0.0001) non-OA
patients. Individuals with a body fat higher than 31% for females and 21%
for males were found to have a signiﬁcant increase in the likelihood of
patient-reported OA (adjusted OR 2.10, conﬁdence interval 1.04, 4.23)
compared to individualswith lower respective body fat percentage. There
was no relationship between BMI and OA in this population.
Conclusions: Body fat, not BMI, is associated with patient-reported OA
status in a Canadian cohort of BMI  30 kg/m2. Further studies are
necessary to understand the association of OA and body fat, and clas-
siﬁcation of a potential metabolic subtype of OA. However, future
clinical studies should consider body fat, in addition to BMI, to more
adequately capture disease risk.
